what does aurobindo pharma do

Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services.

what products does aurobindo pharma make

Aurobindo Pharma manufactures generic pharmaceuticals, active pharmaceutical ingredients, and biosimilars, with specific product presence in semi-synthetic penicillins (SSPs), cephalosporins, antivirals, CNS drugs, cardiovascular drugs, and gastroenterology products.

what sector is aurobindo pharma in

Aurobindo Pharma operates in the pharmaceutical sector, specifically focusing on the manufacturing and marketing of generic drugs and active pharmaceutical ingredients.

when was aurobindo pharma founded

Aurobindo Pharma was founded in 1976.

who owns aurobindo pharma

Aurobindo Pharma is owned by its shareholders, with significant ownership held by institutions and individuals, but it is not specified in the provided context.

Aurobindo Pharma Limited (AUROPHARMA) Share Price Today — ₹1,453.9

Aurobindo Pharma Limited (AUROPHARMA) live stock price is ₹1,453.9. Listed on BSE. Sector: Healthcare. Industry: Pharmaceuticals & Biotechnology.

View Aurobindo Pharma Limited stock charts, financial results, quarterly earnings, shareholding pattern, corporate actions, peer comparison and more on Black Bear Labs.

Compare with other stocks in the Healthcare sector.

Use our Stock CAGR Calculator to calculate returns for Aurobindo Pharma Limited. Screen stocks with our Stock Screener.

Learn about key metrics: P/E Ratio, Market Cap, ROE, EPS.

AUROPHARMA

BSE

F&O

Aurobindo Pharma Limited

Healthcare· Pharmaceuticals & Biotechnology· INE406A01037· Scrip: 524804

EN हिन्दी ગુજરાતી मराठी

₹1,453.90

▲ 7.75 (+0.00%)

2026-06-10

BSE

₹1,453.90

▲ 7.75

+0.00%

230 trading days · 1Y period

TODAY (BSE)

Open1,448.65

High1,467.30

Low1,438.00

Prev Close1,446.15

Volume27,392

Value₹4.0Cr

L: 1,438.00H: 1,467.30

Info

Face Value₹1

Listed2000-07-19

ISININE406A01037

SeriesA

BSE Scrip524804

Key Metrics

1D

—

1W

—

1M

—

3M

—

6M

—

Valuation

P/E (TTM)—

P/E (Qtr Ann.)—

P/Sales—

Mkt Cap—

Growth (QoQ)

Revenue+2.34%

PAT+3.50%

EPS+4.00%

Profitability

EBITDA Margin26.2%

Net Margin10.6%

TTM EBITDA M.26.0%

TTM Net M.11.2%

Dividend

Yield—

Latest DPS₹4

Payout Ratio27.5%

Growth+166.67%

TTM Revenue

₹25815 Cr

TTM EBITDA

₹6704 Cr

TTM PAT

₹2899 Cr

TTM EPS

₹49.69

Rev/Share

₹444.5

Quarterly Financials

Revenue

EBITDA

PAT

EPS

Quarter	Revenue	Expenses	EBITDA	PBT	PAT	EPS
2024-12-31	7979 Cr	6938 Cr	2090 Cr	1198 Cr	846 Cr	₹14.56
2024-09-30	7796 Cr	6725 Cr	2093 Cr	1207 Cr	817 Cr	₹14.00
2024-06-30	2460 Cr	2079 Cr	513 Cr	446 Cr	329 Cr	₹5.62
2024-03-31	7580 Cr	6351 Cr	2009 Cr	1243 Cr	907 Cr	₹15.51
2023-12-31	7352 Cr	6249 Cr	2086 Cr	1265 Cr	940 Cr	₹16.04
2023-09-30	7219 Cr	6332 Cr	1884 Cr	1075 Cr	752 Cr	₹12.83
2023-03-31	6473 Cr	5872 Cr	1361 Cr	736 Cr	506 Cr	₹8.64
2022-12-31	6407 Cr	5819 Cr	1236 Cr	681 Cr	491 Cr	₹8.38

Shareholding Pattern

CURRENT — 2026-03-31

Promoter51.8%

FII15.2%

DII25.9%

Public48.2%

PROMOTER HOLDING TREND

Corporate Actions

Ex-Date	Type	Purpose
2026-04-17	Other	Buy Back
2025-08-08	Dividend	Interim Dividend - Rs 4 Per Share
2024-08-26	Other	Annual General Meeting
2024-07-30	Other	Buy Back
2024-02-20	Dividend	Interim Dividend - Rs 1.50 Per Share
2023-11-20	Dividend	Interim Dividend - Rs 3 Per Share
2023-08-22	Other	Annual General Meeting
2023-02-17	Dividend	Interim Dividend - Rs 3 Per Share
2022-07-27	Other	Annual General Meeting
2022-06-06	Dividend	Interim Dividend - Rs 4.50 Per Share
2022-02-18	Dividend	Interim Dividend - Rs 1.50 Per Share
2021-11-17	Dividend	Interim Dividend - Rs 1.50 Per Share
2021-08-27	Dividend	Interim Dividend - Rs 1.50 Per Share
2021-08-20	Other	Annual General Meeting
2021-02-22	Dividend	Interim Dividend - Rs 1.50 Per Share
2020-11-23	Dividend	Interim Dividend - Rs 1.25 Per Share
2020-08-21	Dividend	Annual General Meeting/Interim Dividend - Rs 1.25 Per Share
2020-02-17	Dividend	Interim Dividend - Rs 1.75 Per Share
2019-11-21	Dividend	Interim Dividend - Rs 1.25 Per Share
2019-08-21	Other	Annual General Meeting

Earnings Transcripts

Aurobindo Pharma Limited has informed the Exchange about Investor Presentation

21 May 2026NSE20K chars

Read →

Aurobindo Pharma Limited has informed the Exchange about schedule of Earnings Call to be held on May...

14 May 2026NSE2K chars

Read →

Aurobindo Pharma Limited has informed the Exchange about Investor Presentation

5 Nov 2025NSE15K chars

Read →

Aurobindo Pharma Limited has informed the Exchange about Investor Presentation

4 Aug 2025NSE14K chars

Read →

Aurobindo Pharma Limited has informed the Exchange about Investor Presentation

26 May 2025NSE15K chars

Read →

Aurobindo Pharma Limited has informed the Exchange about Investor Presentation

6 Feb 2025NSE16K chars

Read →

Price History

Date	Open	High	Low	Close	Volume
2026-06-10	1,443.80	1,468.40	1,437.10	1,453.60	11.24L
2026-06-03	1,432.50	1,458.00	1,419.20	1,440.40	9.69L
2026-05-27	1,463.00	1,473.00	1,428.50	1,435.90	7.92L
2026-05-26	1,450.00	1,467.80	1,449.30	1,461.20	9.51L
2026-05-25	1,455.20	1,465.00	1,428.00	1,454.60	26.84L
2026-05-22	1,520.00	1,520.00	1,445.80	1,463.50	30.39L
2026-05-21	1,523.00	1,550.00	1,515.50	1,546.70	10.14L
2026-05-20	1,510.10	1,539.00	1,505.10	1,517.50	10.69L
2026-05-19	1,500.50	1,530.00	1,499.80	1,512.80	15.39L
2026-05-18	1,514.30	1,525.00	1,491.60	1,500.50	9.39L
2026-05-15	1,519.00	1,528.00	1,503.30	1,511.80	7.07L
2026-05-14	1,504.40	1,525.90	1,497.00	1,510.90	12.07L
2026-05-13	1,490.00	1,509.80	1,483.60	1,497.50	18.22L
2026-05-12	1,486.60	1,504.00	1,478.60	1,488.20	13.43L
2026-05-11	1,487.30	1,505.50	1,477.40	1,486.60	9.25L
2026-05-08	1,485.00	1,513.40	1,480.10	1,487.30	10.18L
2026-05-07	1,475.10	1,498.50	1,469.30	1,478.70	12.28L
2026-05-06	1,431.00	1,489.70	1,426.10	1,484.00	24.21L
2026-05-05	1,373.90	1,431.00	1,367.00	1,428.10	18.12L
2026-05-04	1,398.00	1,398.00	1,367.10	1,376.00	7.78L
2026-04-30	1,392.00	1,404.00	1,378.60	1,389.50	6.06L
2026-04-29	1,425.90	1,433.00	1,389.30	1,396.80	17.39L
2026-04-28	1,415.00	1,430.00	1,410.30	1,422.60	8.48L
2026-04-27	1,414.90	1,433.40	1,386.60	1,416.70	9.98L
2026-04-24	1,436.90	1,446.00	1,411.70	1,413.80	9.68L
2026-04-23	1,420.00	1,459.50	1,409.10	1,435.40	22.38L
2026-04-22	1,389.50	1,425.10	1,382.40	1,421.20	17.04L
2026-04-21	1,368.90	1,401.10	1,367.10	1,391.70	13.63L
2026-04-20	1,392.00	1,392.00	1,363.50	1,367.80	7.07L
2026-04-17	1,388.90	1,394.90	1,375.30	1,386.00	16.12L

Frequently Asked Questions

About

Aurobindo Pharma Limited is an Indian multinational pharmaceutical company based in Hyderabad, specializing in manufacturing and marketing high-quality generic and branded pharmaceuticals, active pharmaceutical ingredients, and biosimilars. It operates globally with U.S. headquarters and is recognized for its leadership in the industry, offering a wide range of affordable healthcare solutions while maintaining a strong market position in both domestic and international markets.

BOARD OF DIRECTORS

Girish Paman Vanvari

Independent Director

Savita Mahajan

Independent Director

DEPARTED

Venkat Nageswar Chalasani

Independent Director

DEPARTED

Deepali Pant Joshi

Additional Director

Mangalam Ramasubramanian Kumar

Additional Director

Mutual Fund Holdings

8 funds · bar length = % to NAVBrowse all funds →

hdfc3 schemes

HDFC Mid Cap Fund

2.04%

₹17.4K Cr

HDFC Large and Mid Cap Fund

1.12%

₹2.8K Cr

HDFC NIFTY MIDCAP 150 INDEX FUND

1.04%

₹5 Cr

baroda3 schemes

Baroda BNP Paribas Health and Wellness Fund

0.03%

₹13 Cr

Baroda BNP Paribas NIFTY Midcap 150 Index Fund

0.01%

₹0 Cr

Baroda BNP Paribas Arbitrage Fund

0.00%

₹0 Cr

wealthcompany1 scheme

WCFL-THE WEALTH COMPANY FLEXI CAP FUND

0.02%

₹5 Cr

ppfas1 scheme

Parag Parikh Arbitrage Fund

0.00%

₹2 Cr